Parthenon LLC Has $2.12 Million Stake in Teleflex Incorporated (NYSE:TFX)

Parthenon LLC trimmed its position in Teleflex Incorporated (NYSE:TFX) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,908 shares of the medical technology company’s stock after selling 75 shares during the period. Parthenon LLC’s holdings in Teleflex were worth $2,119,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of TFX. Cromwell Holdings LLC boosted its stake in shares of Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares during the period. Apollon Wealth Management LLC raised its position in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after purchasing an additional 55 shares during the period. SRS Capital Advisors Inc. lifted its stake in shares of Teleflex by 0.3% during the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after buying an additional 60 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in Teleflex by 0.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after acquiring an additional 65 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. lifted its position in Teleflex by 4.5% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock worth $375,000 after acquiring an additional 66 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Up 3.2 %

TFX opened at $174.74 on Thursday. The stock has a market capitalization of $8.12 billion, a price-to-earnings ratio of 34.74, a P/E/G ratio of 1.67 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $165.62 and a twelve month high of $253.06. The company has a 50-day simple moving average of $177.41 and a 200 day simple moving average of $208.26.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on TFX. Royal Bank of Canada lowered their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial dropped their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.